|
| Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase |
|
https://doi.org/10.18632/oncotarget.28081
Shuai Zhao, Wafik S. El-Deiry
|
| 1970-1979 |
|
| A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs |
|
https://doi.org/10.18632/oncotarget.28079
Kelsey E. Huntington, Anna Louie, Lanlan Zhou, Wafik S. El-Deiry
|
| 1980-1991 |
|
| Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients |
|
https://doi.org/10.18632/oncotarget.28082
Sofia Leaf, Lindsey Carlsen, Wafik S. El-Deiry
|
| 1992-2005 |
|
| Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.28075
Lindsey Carlsen, Christoph Schorl, Kelsey Huntington, Liz Hernandez-Borrero, Aakash Jhaveri, Shengliang Zhang, Lanlan Zhou, Wafik S. El-Deiry
|
| 2006-2021 |
|
| Comparative microsomal proteomics of a model lung cancer cell line NCI-H23 reveals distinct differences between molecular profiles of 3D and 2D cultured cells |
|
https://doi.org/10.18632/oncotarget.28072
Jan A. Kaczmarczyk, Rhonda R. Roberts, Brian T. Luke, King C. Chan, Carly M. Van Wagoner, Robin A. Felder, Richard G. Saul, Colantonio Simona, Josip Blonder
|
| 2022-2038 |
|
| Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma |
|
https://doi.org/10.18632/oncotarget.28074
Nicholas Cho, Sooah Ko, Monica Shokeen
|
| 2039-2050 |
|
| Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.28067
Trupti Vardam-Kaur, Latha B. Pathangey, Daniel J. McCormick, P. Leif Bergsagel, Peter A. Cohen, Sandra J. Gendler
|
| 2051-2067 |
|
| NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells |
|
https://doi.org/10.18632/oncotarget.28063
Adam S. Kittai, Olga V. Danilova, Vi Lam, Tingting Liu, Nur Bruss, Scott Best, Guang Fan, Alexey V. Danilov
|
| 2068-2074 |
|
| Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.28060
Ricardo Paz-Fumagalli, Jacob Core, Carlos Padula, Seyed Montazeri, John McKinney, Gregory Frey, Zlatko Devcic, Andrew Lewis, Charles Ritchie, Kabir Mody, Sunil Krishnan, Beau Toskich
|
| 2075-2088 |
|
| Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.28080
Hung Q. Doan, Leon Chen, Zeena Nawas, Heng-Huan Lee, Sirunya Silapunt, Michael Migden
|
| 2089-2100 |
|
| Fibrocytes in primary myelofibrosis |
|
https://doi.org/10.18632/oncotarget.27971
Kazuya Shimoda, Yoshinori Ozono, Kotaro Shide
|
| 2101-2103 |
|
| Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers |
|
https://doi.org/10.18632/oncotarget.27983
Austin R. Dosch, Walid K. Chatila, Yuguang Ban, Anna Bianchi, Nilesh U. Deshpande, Iago De Castro Silva, Nipun B. Merchant, Jashodeep Datta
|
| 2104-2110 |
|
| Correction: PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway |
|
https://doi.org/10.18632/oncotarget.28087
Dong Tang, Jingqiu Zhang, Zhongxu Yuan, Hongpeng Zhang, Yang Chong, Yuqin Huang, Jie Wang, Qingquan Xiong, Sen Wang, Qi Wu, Ying Tian, Yongdie Lu, Xiao Ge, Wenjing Shen, Daorong Wang
|
| 2111-2113 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
